SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY)
TRIB 1.0700.0%Dec 12 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: AgAuUSA who wrote (9632)7/2/1998 10:26:00 PM
From: dowman  Read Replies (4) of 14328
 
Sending a list of "products" from Triby does not address the issue.
Triby has no license to use HIV2 in this country. And if the FDA does
not reverse their current position, which is possible, they will not have an HIV test to sell in this country. The FDA site you posted shows no evidence of Trinity under any HIV2 listing. And your posting the "marketing list" brings up another basis question. What are the revenues of all these products? From a 1995 Trinity press release about a 3 year $21 million EPT contract, it would appear that about $7 million of last years revenue was from the pregnancy test. Thus slightly over $9 million in last years sales are divided among the remaining 89 product offerings. Sure sounds a little cumbersome to me. No wonder they refuse to disclose sales by product line
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext